
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Defining the role of natural killer cells in COVID-19
Madeline Lee, Catherine A. Blish
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1628-1638
Open Access | Times Cited: 36
Madeline Lee, Catherine A. Blish
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1628-1638
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer
Aristo Vojdani, Sadi Köksoy, Elroy Vojdani, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 230-230
Open Access | Times Cited: 25
Aristo Vojdani, Sadi Köksoy, Elroy Vojdani, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 230-230
Open Access | Times Cited: 25
SARS-CoV-2 immunity in animal models
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 18
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 18
Systems analysis of innate and adaptive immunity in Long COVID
Michael J. Peluso, Mohamed Abdel‐Mohsen, Timothy J. Henrich, et al.
Seminars in Immunology (2024) Vol. 72, pp. 101873-101873
Closed Access | Times Cited: 14
Michael J. Peluso, Mohamed Abdel‐Mohsen, Timothy J. Henrich, et al.
Seminars in Immunology (2024) Vol. 72, pp. 101873-101873
Closed Access | Times Cited: 14
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 10
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 10
Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung
Cameron R. Bishop, Kexin Yan, Wilson Nguyen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Cameron R. Bishop, Kexin Yan, Wilson Nguyen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Induction of protective immune responses at respiratory mucosal sites
Seok‐Chan Park, Matthew J. Wiest, Vivian Yan, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Seok‐Chan Park, Matthew J. Wiest, Vivian Yan, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 9
TLR2/4 are novel activating receptors for SARS-CoV-2 spike protein on NK cells
Nadine Landolina, Biancamaria Ricci, Irene Veneziani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Nadine Landolina, Biancamaria Ricci, Irene Veneziani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease
Jung A Eom, Jin‐Ju Jeong, Sang Hak Han, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 15
Jung A Eom, Jin‐Ju Jeong, Sang Hak Han, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 15
The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases
Aleksandra Pogoda-Wesołowska, Nina Sługocka, Agnieszka Synowiec, et al.
Frontiers in Molecular Neuroscience (2025) Vol. 17
Open Access
Aleksandra Pogoda-Wesołowska, Nina Sługocka, Agnieszka Synowiec, et al.
Frontiers in Molecular Neuroscience (2025) Vol. 17
Open Access
Navigating the Unknown: Open Questions Surrounding Natural Killer Cell Responses to SARS-CoV-2
Quirin Hammer
Springer eBooks (2025), pp. 1-21
Closed Access
Quirin Hammer
Springer eBooks (2025), pp. 1-21
Closed Access
Single-cell transcriptome-wide Mendelian randomization and colocalization reveals immune-mediated regulatory mechanisms and drug targets for COVID-19
Ying Hui, Xueyan Wu, Xiaojing Jia, et al.
EBioMedicine (2025) Vol. 113, pp. 105596-105596
Open Access
Ying Hui, Xueyan Wu, Xiaojing Jia, et al.
EBioMedicine (2025) Vol. 113, pp. 105596-105596
Open Access
The causal effect of natural killer cells on COVID-19 infection, hospitalization and severity
Kaili Yang, Jun Quan, Zhi Long Liu, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access
Kaili Yang, Jun Quan, Zhi Long Liu, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access
Immune dysregulation in long covid may contribute to the development of neurological disorders through the effects of cytokines
В. В. Рассохин, N. A. Аrsentieva, Zoia R. Korobova, et al.
HIV Infection and Immunosuppressive Disorders (2025) Vol. 16, Iss. 4, pp. 7-16
Open Access
В. В. Рассохин, N. A. Аrsentieva, Zoia R. Korobova, et al.
HIV Infection and Immunosuppressive Disorders (2025) Vol. 16, Iss. 4, pp. 7-16
Open Access
The common genetic variant rs1278960 determining expression of Interferon-lambda predicts inflammatory response in critically ill COVID-19 patients
Timo Mayerhöfer, Michael Joannidis, Sebastian Klein, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Timo Mayerhöfer, Michael Joannidis, Sebastian Klein, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Structural Basis of SARS-CoV-2 Nsp13-Derived Peptide-Mediated NK Cell Activation
Xiaole Xu, Song Luo, Jinxin Liu, et al.
Biomacromolecules (2025)
Closed Access
Xiaole Xu, Song Luo, Jinxin Liu, et al.
Biomacromolecules (2025)
Closed Access
The Role of NKG2D and Its Ligands in Autoimmune Diseases: New Targets for Immunotherapy
Leiyan Wei, Zhiqing Xiang, Yizhou Zou
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17545-17545
Open Access | Times Cited: 9
Leiyan Wei, Zhiqing Xiang, Yizhou Zou
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17545-17545
Open Access | Times Cited: 9
Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice
Agnes Carolin, Kexin Yan, Cameron Bishop, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Agnes Carolin, Kexin Yan, Cameron Bishop, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
NK Cell–Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19
Madeline Lee, Izumi de los Rios Kobara, Trisha R. Barnard, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 11, pp. 1693-1705
Open Access | Times Cited: 3
Madeline Lee, Izumi de los Rios Kobara, Trisha R. Barnard, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 11, pp. 1693-1705
Open Access | Times Cited: 3
The role of inflammatory gene polymorphisms in severe COVID-19: a review
J Yip, Adrian Oo, Yan Ling Ng, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
J Yip, Adrian Oo, Yan Ling Ng, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1
Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri‐Bowen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri‐Bowen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency
Lucy Kundura, Renaud Cezar, Emma Ballongue, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 7, pp. 1105-1112
Open Access | Times Cited: 2
Lucy Kundura, Renaud Cezar, Emma Ballongue, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 7, pp. 1105-1112
Open Access | Times Cited: 2
Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease
Daniel Fernández‐Soto, Álvaro F. García-Jiménez, José M. Casasnovas, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Daniel Fernández‐Soto, Álvaro F. García-Jiménez, José M. Casasnovas, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Immunometabolic features of natural killer cells are associated with infection outcomes in critical illness
Kuei‐Pin Chung, Jia-Ying Su, Yi‐Fu Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Kuei‐Pin Chung, Jia-Ying Su, Yi‐Fu Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Successful salvage of a severe COVID-19 patient previously with lung cancer and radiation pneumonitis by mesenchymal stem cells: a case report and literature review
Xiaohua Huang, Xin Tan, Xiuwen Xie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Xiaohua Huang, Xin Tan, Xiuwen Xie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit
Jozef Nahálka
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4440-4440
Open Access | Times Cited: 1
Jozef Nahálka
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4440-4440
Open Access | Times Cited: 1